We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
Browsing: Head and Neck
Oropharyngeal Cancer, Hypopharyngeal Cancer, Laryngeal Cancer, Lip and Oral Cavity Cancer, Nasopharyngeal Cancer, Paranasai Sinus and Nasal Cavity Cancer, Salivary Gland Cancer, Squamous Cell Neck Cancer, Soft Tissue Sarcoma, Thyroid Cancer, News and Information
I think the field of cancer and in particular, head neck cancer has been. Somewhat revolutionized with the introduction of…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
In this episode of The Onco’Zine Brief Peter Hofland talks with Peggy Berry, Vice president of Global Regulatory Affairs at…
Brianna Jones, MD, BS from the Icahn School of Medicine at Mount Sinai discusses ASTRO Abstract 3885 Pathologic Features and…
Barbara Burtness, MD of the Yale Cancer Center discusses the ASCO 2020 Abstract Correlation of tumor mutational burden (TMB) with…
Prof. Jean Bourhis, Department Head of Radio-Oncology at the University Hospital of Lausanne and Lead Investigator of Centre Hospitalier Universitaire…
J. Mel Sorensen, MD President, and Chief Executive Officer Galera Thereptutics, Inc gives an overview from ASCO 2020 abstract entitled…
Dan Paul Zandberg, MD at UPMC discusses an ASCO 2020 abstract entitled The impact of tumor hypoxia on the clinical…
Paz J. Vellanki, MD from U.S. Department of Health and Human Services discusses an ASCO 2020 abstract entitled Evaluation of…
Lillian Siu, MD Princess Margaret Cancer Centre discusses an ASCO 2020 abstract entitled Phase III LEAP-010 study: first-line pembrolizumab with…
Catherine Haring, MD & Paul Swiecicki, MD from University of Michigan Medical School discuss an ASCO 2020 abstract entitled HPV…
Ralph Zinner, MD University of Kentucky discusses an ASCO 2020 abstract entitled Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and…
Michelle Echevarria, MD from Moffitt Cancer Center discusses an ASCO 2020 Phase I dose escalation of stereotactic body radiation therapy…
Kedar Kirtane, MD from Moffitt Cancer Center discusses an ASCO 2020 abstract entitled Concurrent cetuximab (CTX) and nivolumab (NIVO) in…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Total glossectomy is a surgical option for patients with advanced (stage IV cancers) or recurrent tongue cancer. Advanced cancer of…
Buccal cancer involving masticator space grows rapidly and penetrates well with a high recurrence rate due its aggressive nature. The…
Kevin Harrington, PhD, MBBS, of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust discusses KEYNOTE-048: progression…
Kevin Harrington, PhD, MBBS, of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust discusses KEYNOTE-048: progression…
Kevin Harrington, PhD, MBBS, of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust discusses KEYNOTE-048: progression…
Cherie-Ann O. Nathan, MD of LSU Health Shreveport @LSUHS @LSUHealthNO answers if this will affect clinicians and treatment for progression-free…
Cherie-Ann O. Nathan, MD of LSU Health Shreveport @LSUHS @LSUHealthNO answers what type of TP53 mutations benefited from this for…
Cherie-Ann O. Nathan, MD of LSU Health Shreveport @LSUHS @LSUHealthNO answers questions on immunotherapy for a drug used for breast…
Cherie-Ann O. Nathan, MD of LSU Health Shreveport @LSUHS @LSUHealthNO discusses a drug used for breast and kidney cancer may…
In Roswell Park study, 42% of patients who received gabapentin for pain managementrequired no narcotics Most patients treated for head…
Anurag Singh, MD of Roswell Park explains what’s next in research. ______ Roswell Park researchers present findings at ASTRO Annual…
Anurag Singh, MD of Roswell Park explains a commonly asked question by colleagues: why is there no benefit to cancer…
Anurag Singh, MD of Roswell Park reveals that patients with some cancers who have taken baby aspirin can improve overall…
Roswell Park researchers present findings at ASTRO Annual Meeting Aspirin improved overall survival for patients with head/neck, lung cancers Patients…
Danny Rischin, MD, Division of Cancer Medicine, Department of Medical Oncology, Peter MacCallum Cancer Centre, Professor of Medicine, University of…
Danny Rischin, MD, Division of Cancer Medicine, Department of Medical Oncology, Peter MacCallum Cancer Centre, Professor of Medicine, University of…
Danny Rischin, MD, Division of Cancer Medicine, Department of Medical Oncology, Peter MacCallum Cancer Centre, Professor of Medicine, University of…
Michael R. Migden, M.D., discusses locally advanced cutaneous squamous cell carcinoms. Background: Cemiplimab (REGN2810) produced substantial antitumor activity with durable…